QA: Aravive Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513818_2022_Aravive_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001513818, Aravive Inc

  xvar xval
0 AssetsCurrent 62,745,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 400,000
3 remainder_Assets 4,642,000
4 LiabilitiesCurrent 17,941,000
5 LiabilitiesNoncurrent 7,624,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,123,981
9 ResearchAndDevelopmentExpense 48,107,424
10 remainder_Expenses 5,777,224
11 remainder_Revenues 6,799,427
12 remainder_NetIncome 1,080,327
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 67,787,000
1 Liabilities 25,565,000
2 Expenses 63,008,629
3 Revenues 6,799,427
4 StockholdersEquity 42,222,000
5 NetIncome -55,128,875
6 ComprehensiveNetIncome -55,128,875
7 BaseVar 82,120,192
8 EconomicCapitalRatiobeforeLimitedLiability 0.791
9 EconomicCapitalRatio 2.13

Edgar->Model Mapping

Feature Distribution

Change over Time